semaglutide kidney side effects Research shows — commonly sold as Ozempic or Wegovy — can improve function and survival rates for people with some chronic diseases, even if they have heart issues. ✍️ Health Ozempic (Semaglutide): GLP-1 receptor agonist

"Many patients who would otherwise be considered 'too sick for surgery' may now qualify." Patients with extreme obesity, a body mass index (BMI) of 70 or more, face a higher risk of complications from surgery compared to patients with lower BMIs

Recently, LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Results) study shows that GLP-1 analogue liraglutide treatment reduces the rates of cardiovascular events and death in patients with type 2 diabetes 9

Standards and quality controls were prepared by spiking L2-Cmu into mouse plasma

Those with established cardiovascular disease also benefit, as semaglutide has demonstrated cardiovascular event reduction in landmark trials